FR2426694B1 - - Google Patents

Info

Publication number
FR2426694B1
FR2426694B1 FR7913524A FR7913524A FR2426694B1 FR 2426694 B1 FR2426694 B1 FR 2426694B1 FR 7913524 A FR7913524 A FR 7913524A FR 7913524 A FR7913524 A FR 7913524A FR 2426694 B1 FR2426694 B1 FR 2426694B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7913524A
Other versions
FR2426694A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB23041/78A external-priority patent/GB1604723A/en
Priority claimed from GB2304278A external-priority patent/GB1604724A/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2426694A1 publication Critical patent/FR2426694A1/fr
Application granted granted Critical
Publication of FR2426694B1 publication Critical patent/FR2426694B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7913524A 1978-05-26 1979-05-28 Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique Granted FR2426694A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB23041/78A GB1604723A (en) 1978-05-26 1978-05-26 7-(2-aminothiazol-4-yl)-2-oxyimino-acetamido)-cephem derivatives
GB2304278A GB1604724A (en) 1978-05-26 1978-05-26 7-(2-aminothiazol-4-yl)-2-oxymino-acedamido)-cephem derivatives
GB7842196 1978-10-27
GB7842166 1978-10-27

Publications (2)

Publication Number Publication Date
FR2426694A1 FR2426694A1 (fr) 1979-12-21
FR2426694B1 true FR2426694B1 (fr) 1984-10-26

Family

ID=27448575

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913524A Granted FR2426694A1 (fr) 1978-05-26 1979-05-28 Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique

Country Status (21)

Country Link
US (1) US4621081A (fr)
AR (2) AR229882A1 (fr)
AT (2) AT369748B (fr)
AU (1) AU524734B2 (fr)
CH (1) CH648851A5 (fr)
DE (1) DE2921332A1 (fr)
DK (1) DK216879A (fr)
ES (3) ES480916A1 (fr)
FI (1) FI791679A (fr)
FR (1) FR2426694A1 (fr)
HU (1) HU182960B (fr)
IE (1) IE49175B1 (fr)
IL (1) IL57398A (fr)
IT (1) IT1116185B (fr)
LU (1) LU81320A1 (fr)
NL (1) NL7904123A (fr)
NO (1) NO791730L (fr)
NZ (1) NZ190559A (fr)
PH (1) PH15928A (fr)
PT (3) PT69672A (fr)
SE (1) SE7904577L (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE878514A (fr) * 1978-09-04 1980-02-29 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3-cephem-4-carboxylique a disubstitution en positions 3 et 7, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
FR2476647A2 (fr) * 1980-02-26 1981-08-28 Roussel Uclaf Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn
GR75487B (fr) * 1981-06-22 1984-07-23 Fujisawa Pharmaceutical Co
FR2516515A1 (fr) * 1981-11-16 1983-05-20 Sanofi Sa Nouveaux derives de pyridinium thiomethyl cephalosporines, procede pour leur preparation et compositions pharmaceutiques les contenant
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
KR920004820B1 (ko) * 1984-02-23 1992-06-18 메이지제과 주식회사 새로운 세팔로스포린 유도체의 제조방법
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPH064645B2 (ja) * 1985-11-27 1994-01-19 明治製菓株式会社 新規セフアロスポリン誘導体およびそれを含む抗菌剤
US4880797A (en) * 1986-03-20 1989-11-14 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives and antibacterial agents
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63154622A (ja) * 1986-12-18 1988-06-27 Meiji Seika Kaisha Ltd セフアロスポリン誘導体を有効成分とする哺乳動物用抗菌剤
JPH01254686A (ja) * 1988-04-05 1989-10-11 Katayama Seiyakushiyo:Kk セフエム化合物およびその製造法
US5202315A (en) * 1989-05-11 1993-04-13 Lucky, Ltd. Cephalosporin compounds
EP0449515B1 (fr) * 1990-03-24 1995-05-24 Lucky, Ltd. Intermédiaires de céphalosporine et procédé pour leur préparation ainsi que la préparation de leurs produits finaux
AU656886B2 (en) * 1990-11-09 1995-02-23 Lucky Limited Novel cephalosporin compounds and processes for preparation thereof
KR0154901B1 (ko) * 1992-12-26 1998-11-16 성재갑 신규 세팔로스포린계 항생제(v)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4095021A (en) * 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
IE49211B1 (en) * 1978-11-17 1985-08-21 Glaxo Group Ltd Cephalosporin antibiotics
ES8103101A1 (es) * 1979-03-22 1981-02-16 Glaxo Group Ltd Un procedimiento para la preparacion de antibioticos de ce- falosporina
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
FR2426694A1 (fr) 1979-12-21
AU4742079A (en) 1979-11-29
PT69671A (en) 1979-06-01
SE7904577L (sv) 1980-02-11
IE791027L (en) 1979-11-26
FI791679A (fi) 1979-11-27
ATA590580A (de) 1982-06-15
DE2921332A1 (de) 1979-11-29
IL57398A0 (en) 1979-09-30
AT369749B (de) 1983-01-25
ES480916A1 (es) 1980-02-01
ATA590680A (de) 1982-06-15
AR229882A1 (es) 1983-12-30
AU524734B2 (en) 1982-09-30
NZ190559A (en) 1982-05-25
DK216879A (da) 1979-11-27
LU81320A1 (fr) 1979-09-11
AR231986A1 (es) 1985-04-30
PT69673A (en) 1979-06-01
US4621081A (en) 1986-11-04
IT1116185B (it) 1986-02-10
PT69672A (en) 1979-06-01
PH15928A (en) 1983-04-27
NL7904123A (nl) 1979-11-28
HU182960B (en) 1984-03-28
AT369748B (de) 1983-01-25
NO791730L (no) 1979-11-27
IT7949176A0 (it) 1979-05-25
ES480918A1 (es) 1980-02-01
CH648851A5 (de) 1985-04-15
IL57398A (en) 1982-12-31
IE49175B1 (en) 1985-08-21
ES480917A1 (es) 1980-02-01

Similar Documents

Publication Publication Date Title
AU3898778A (fr)
AU3803078A (fr)
AU73950S (fr)
AU3892778A (fr)
BG25974A1 (fr)
BG25917A1 (fr)
BE871570A (fr)
BG25806A1 (fr)
BG25814A2 (fr)
BG25816A1 (fr)
BG25818A1 (fr)
BG25835A1 (fr)
BG25836A1 (fr)
BG25842A1 (fr)
BG25843A1 (fr)
BG25849A1 (fr)
BG25854A1 (fr)
BG25857A1 (fr)
BG25858A1 (fr)
BG25871A1 (fr)
BG25872A1 (fr)
BG25874A1 (fr)
BG25875A1 (fr)
BG25879A1 (fr)
BG25889A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse